ConvaTec Group Plc
Results of Annual General Meeting
Reading, United Kingdom 7 May 2021 - Poll Result
ConvaTec Group Plc ("ConvaTec") held its annual general meeting today ("AGM"). The results of the poll held in relation to the resolutions proposed at the AGM are set out below:
|
For (see note 2) |
Against (see note 2) |
Total Votes cast |
% of ISC Voted |
Number of Votes Withheld (see note 3) |
|||
Resolution |
No of shares |
% |
No of shares |
% |
||||
1 |
Receive Annual Report and Accounts |
1,744,608,352 |
99.96 |
777,616 |
0.04 |
1,745,385,968 |
87.08% |
1,480,001 |
2 |
Approve the Directors' Remuneration Report |
1,698,130,077 |
97.23 |
48,413,492 |
2.77 |
1,746,543,569 |
87.14% |
322,400 |
3 |
Declare Final Dividend |
1,740,839,314 |
99.66 |
5,915,934 |
0.34 |
1,746,755,248 |
87.15% |
110,721 |
4 |
Re-elect John McAdam as a director |
1,726,805,777 |
98.88 |
19,520,971 |
1.12 |
1,746,326,748 |
87.13% |
539,221 |
5 |
Re-elect Karim Bitar as a director |
1,745,847,330 |
99.95 |
907,151 |
0.05 |
1,746,754,481 |
87.15% |
111,488 |
6 |
Re-elect Frank Schulkes as a director |
1,739,573,569 |
99.59 |
7,176,168 |
0.41 |
1,746,749,737 |
87.15% |
116,232 |
7 |
Re-elect Margaret Ewing as a director |
1,735,171,507 |
99.34 |
11,573,127 |
0.66 |
1,746,744,634 |
87.15% |
121,335 |
8 |
Re-elect Brian May as a director |
1,726,852,048 |
98.86 |
19,898,392 |
1.14 |
1,746,750,440 |
87.15% |
115,529 |
9 |
Re-elect Rick Anderson as a director |
1,732,922,453 |
99.21 |
13,822,181 |
0.79 |
1,746,744,634 |
87.15% |
121,335 |
10 |
Re-elect Regina Benjamin as a director |
1,733,824,898 |
99.26 |
12,925,036 |
0.74 |
1,746,749,934 |
87.15% |
116,035 |
11 |
Re-elect Sten Scheibye as a director |
1,745,567,146 |
99.93 |
1,187,335 |
0.07 |
1,746,754,481 |
87.15% |
111,488 |
12 |
Elect Heather Mason as a director |
1,744,886,278 |
99.89 |
1,863,459 |
0.11 |
1,746,749,737 |
87.15% |
116,232 |
13 |
Elect Constantin Coussios as a director |
1,744,393,943 |
99.87 |
2,356,497 |
0.13 |
1,746,750,440 |
87.15% |
115,529 |
14 |
Re-appoint Deloitte LLP as auditor |
1,746,633,262 |
99.99 |
118,345 |
0.01 |
1,746,751,607 |
87.15% |
114,362 |
15 |
Authorise the directors to determine the remuneration of the Company's auditor |
1,746,753,488 |
100.00 |
433 |
0.00 |
1,746,753,921 |
87.15% |
112,048 |
16 |
Authorise political donations and political expenditure |
1,721,717,493 |
98.58 |
24,812,022 |
1.42 |
1,746,529,515 |
87.14% |
336,454 |
17 |
Authorise allotment of shares |
1,623,589,106 |
92.97 |
122,709,426 |
7.03 |
1,746,298,532 |
87.13% |
567,437 |
18 |
Disapply pre-emption rights* |
1,736,680,253 |
99.45 |
9,522,182 |
0.55 |
1,746,202,435 |
87.12% |
663,534 |
19 |
Disapply pre-emption rights in connection with an acquisition or specified capital investment* |
1,691,979,685 |
96.87 |
54,580,936 |
3.13 |
1,746,560,621 |
87.14% |
305,348 |
20 |
Authorise purchase of own shares* |
1,741,411,621 |
99.75 |
4,350,959 |
0.25 |
1,745,762,580 |
87.10% |
1,103,389 |
21 |
Call general meetings on 14 days' notice* |
1,657,330,730 |
94.88 |
89,418,003 |
5.12 |
1,746,748,733 |
87.15% |
117,236 |
*Special Resolution
NOTES:
1. All resolutions were passed.
2. Votes "For" and "Against" are expressed as a percentage of votes received.
3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
4. Total number of shares in issue at close of business on 5 May 2021 was 2,004,347,138 shares; 87.15% of voting capital was instructed.
5. Computershare acted as scrutineer of the poll on all resolutions.
In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Meeting will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com
Enquiries
Analysts and Investors
Kate Postans, Vice President Investor Relations, ConvaTec +44 (0)7826 447 807
Media
Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
# # #
END